Citation: E. Hollander et Cm. Wong, Spectrum, boundary, and subtyping issues: Implications for treatment-refractory obsessive-compulsive disorder, LEA SER PER, 2000, pp. 3-22
Citation: Sl. Rauch et Cr. Savage, Investigating cortico-striatal pathophysiology in obsessive-compulsive disorders: Procedural learning and imaging probes, LEA SER PER, 2000, pp. 133-154
Citation: Pm. Salkovskis et al., Psychological treatment of refractory obsessive-compulsive disorder and related problems, LEA SER PER, 2000, pp. 201-221
Citation: Ta. Pigott et S. Seay, Pharmacotherapy of obsessive-compulsive disorder: Overview and treatment-refractory strategies, LEA SER PER, 2000, pp. 277-302
Authors:
Iancu, I
Dannon, PN
Lustig, M
Sasson, Y
Zohar, J
Citation: I. Iancu et al., Preferential efficacy of serotonergic medication in obsessive-compulsive disorder: From practice to theory, LEA SER PER, 2000, pp. 303-313
Citation: Mj. Kozak et al., Cognitive behavior therapy and pharmacotherapy for obsessive-compulsive disorder: The NIMH-sponsored collaborative study, LEA SER PER, 2000, pp. 501-530